NCT02320851

Brief Summary

The purpose of this study is to evaluate the efficacy of a manualised, multimodal group psychotherapy, based on integrative psychotherapy (IPT) and tailored to somatoform vertigo/dizziness (SVD) subgroups of mental disorders, compared to self-help groups (SHGs) in patients with SVD. The investigators hypothesise that patients who received IPT will demonstrate greater improvement concerning their vertigo-related handicap compared to patients from the SHGs. The investigators will also analyse the cost-effectiveness of experimental and control intervention.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
216

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2015

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
13 days until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

December 19, 2014

Status Verified

December 1, 2014

Enrollment Period

2.5 years

First QC Date

December 16, 2014

Last Update Submit

December 18, 2014

Conditions

Keywords

Somatoform disorderFunctional vertigo/dizzinessChronic subjective dizziness

Outcome Measures

Primary Outcomes (1)

  • Vertigo-related quality of life

    Absolute improvement of vertigo-related quality of life on the Vertigo Handicap Questionnaire (VHQ) at 12 months after the 16-week therapy sessions from VHQ at randomisation/baseline.

    Improvement at follow-up (12 months after treatment)

Secondary Outcomes (6)

  • Generic quality of life

    Improvement at follow-up (12 months after treatment)

  • Severity of vertigo

    Improvement at follow-up (12 months after treatment)

  • Depression

    Improvement at follow-up (12 months after treatment)

  • Anxiety

    Improvement at follow-up (12 months after treatment)

  • Somatisation

    Improvement at follow-up (12 months after treatment)

  • +1 more secondary outcomes

Other Outcomes (1)

  • Cost-effectiveness

    Baseline and follow-up (12 months after treatment)

Study Arms (2)

SVD-tailored Integrative Psychotherapy (IPT)

EXPERIMENTAL

IPT is a short-term psychotherapy aiming to ameliorate both physical and psychosocial distress. It emanates from a multidirectional and dynamic relationship among body, mind, and environment irrespective of causality. In a multi-component approach, other elements are integrated into it, such as cognitive-behavioral and psychodynamic techniques, psychoeducation and body-oriented techniques. The IPT intervention tailored to SVD will be delivered for 16 weeks in a manualised setting with one group session per week (à 90 minutes) and one additional booster session three months after the end of the therapy. The group psychotherapy is on a 6-8:1 basis and will be conducted by a psychotherapist trained on the basis of the manual and under regular clinical supervision.

Behavioral: SVD-tailored Integrative Psychotherapy (IPT)

Self-help group (SHG)

ACTIVE COMPARATOR

The experimental condition will be compared to moderated self-help groups without the implementation of additional therapeutic interventions. Those can be classified as low-level non-placebo control. Treatment will consist of 16 weekly moderated SHG sessions (one weekly session à 90 minutes) and one additional booster-session at three months after the end of the control intervention to be delivered on a 6-8:1 basis by a trained SHG moderator under clinical supervision.

Behavioral: Self-help group (SHG)

Interventions

(see description of corresponding study arm)

SVD-tailored Integrative Psychotherapy (IPT)

(see description of corresponding study arm)

Self-help group (SHG)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • SVD diagnosis
  • Clinically relevant SVD (VHQ sum score \> 45)
  • Informed consent

You may not qualify if:

  • Insufficient German language ability
  • Insufficient cognitive abilities (Mini Mental State Test (MMST) ≤ 27)
  • Severe and chronic comorbid somatic or mental disease (e.g., suicidality, severe depression, drug addiction)
  • Current psychotherapeutic treatment
  • Living \> 50 km away from Munich

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Limburg K, Radziej K, Sattel H, Henningsen P, Dieterich M, Probst T, Dale R, Lahmann C. A Randomized Controlled Trial Evaluating Integrative Psychotherapeutic Group Treatment Compared to Self-Help Groups in Functional Vertigo/Dizziness. J Clin Med. 2021 May 20;10(10):2215. doi: 10.3390/jcm10102215.

  • Lahmann C, Henningsen P, Dieterich M, Radziej K, Schmid G. Tailored care for somatoform vertigo/dizziness: study protocol for a randomised controlled trial evaluating integrative group psychotherapy. J Neurol. 2015 Aug;262(8):1867-75. doi: 10.1007/s00415-015-7784-6. Epub 2015 May 23.

MeSH Terms

Conditions

DizzinessSomatoform Disorders

Interventions

Self-Help Groups

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Claas Lahmann, PD Dr. med.

    Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Universitaet, Munich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gabriele Schmid, Dr. phil. Dipl.-Psych.

CONTACT

Katharina Radziej, Dipl.-Psych.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2014

First Posted

December 19, 2014

Study Start

January 1, 2015

Primary Completion

July 1, 2017

Study Completion

October 1, 2017

Last Updated

December 19, 2014

Record last verified: 2014-12